Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort SMART 1-2 Inhalations b.i.d. as Maintenance Therapy Plus Additional Inhalations as-Needed, Compared to Patients Treated With a Free Combination of an Inhaled Glucocorticosteroid and an Inhaled Long Acting beta-2-Agonist Plus as Needed Inhalations of a Short Acting beta-2 Agonist.

Next Previous
Trial Profile

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort SMART 1-2 Inhalations b.i.d. as Maintenance Therapy Plus Additional Inhalations as-Needed, Compared to Patients Treated With a Free Combination of an Inhaled Glucocorticosteroid and an Inhaled Long Acting beta-2-Agonist Plus as Needed Inhalations of a Short Acting beta-2 Agonist.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Beta 2 adrenergic receptor agonists; Corticosteroids
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca

Most Recent Events

  • 02 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 14 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
  • 15 Oct 2009 Planned number of patients changed from 600 to 500 as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top